Description
Recombinant monoclonal antibody to HLA-DR. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 1D10 (Hu1D10; Apolizumab).
Target
HLA-DR
Target Alias Names
CD74, HLA class II histocompatibility antigen gamma chain, HLA-DR antigens-associated invariant chain, Ia antigen-associated invariant chain, Ii, p33
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Methods
Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression